| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/25/2011 | CN101401876B Chinese medicinal composition for treating upper respiratory tract infection |
| 05/25/2011 | CN101401789B Cordyceps sinensis polysaccharide liposome medicament and preparation thereof |
| 05/25/2011 | CN101390925B Composite immunity strengthening agent for fresh water young fish |
| 05/25/2011 | CN101374814B Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them |
| 05/25/2011 | CN101374808B Indole sulfonamide modulators of progesterone receptors |
| 05/25/2011 | CN101370787B 2-(phenyl or heterocyclic)-1H-phenantrho[9,10-d]imidazoles as mPGES-1 inhibitors |
| 05/25/2011 | CN101342184B Use of oligosaccharides in preparing nutritional or pharmaceutical composition |
| 05/25/2011 | CN101336918B Use of annonaceous acetogenins in preparing medicine for treating lung cancer or breast cancer |
| 05/25/2011 | CN101328169B Diethylcarbamyl-substituted thiazole dihydropyrimidine |
| 05/25/2011 | CN101321528B 3 , llb-cis-dihydrotetrabenazine for the treatment of a proliferative disease or an inflammation |
| 05/25/2011 | CN101297867B Cigarette for quitting drug and preparation thereof |
| 05/25/2011 | CN101297819B Chinese medicinal composition for curing cervical erosion and preparation method thereof |
| 05/25/2011 | CN101292969B Application of butyric acid (butanoic acid) in preparing medicaments for treating anorectal diseases |
| 05/25/2011 | CN101278963B Liquid medicament for curing bedsore |
| 05/25/2011 | CN101273046B Indol-3-yl-carbonyl-azaspiro derivatives as vasopressin receptor antagonists |
| 05/25/2011 | CN101272783B (indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid CB1 receptor |
| 05/25/2011 | CN101259134B New pharmaceutical use of echinacoside |
| 05/25/2011 | CN101259102B Micrometre level docosahexaenoic acid emulsion and preparation thereof |
| 05/25/2011 | CN101250206B Effective part containing cyaniding 3-O-glucoside as well as preparation method and use thereof |
| 05/25/2011 | CN101244104B Method for increasing rare saponin content in panax ginseng total saponin extract |
| 05/25/2011 | CN101237870B Concomitant pharmaceutical agents and use thereof |
| 05/25/2011 | CN101233140B Novel camptothecin analogues compounds, a method for the preparation thereof and pharmaceutical compositions containing said compounds |
| 05/25/2011 | CN101213184B Heteroaryl-substituted amides comprising an unsaturated or cyclic linker group, and their use as pharmaceuticals |
| 05/25/2011 | CN101185759B Anti-angiogene compositions and methods of use |
| 05/25/2011 | CN101171257B Pyrrolobenzodiazepines compound |
| 05/25/2011 | CN101160308B Pharmacetically acceptable salt with decoquinate ketone compound with improved medicine performance |
| 05/25/2011 | CN101160120B Sedative effect-providing agent and sedative fragrance composition containing the same |
| 05/25/2011 | CN101137387B Pharmaceutical composition and method for neoangiogenesis/revascularization useful in treating ischemic heart diseases |
| 05/25/2011 | CN101137371B Process for preparing lansoprazole |
| 05/25/2011 | CN101133055B MELEIMId derivative for treating cancer, compositions and methods |
| 05/25/2011 | CN101128431B Novel quinoline derivatives as potassium ion channel openers |
| 05/25/2011 | CN101068793B Potassium salt of an HIV integrase inhibitor |
| 05/25/2011 | CN101062037B Process for their preparation of thioxanthine derivatives, their use |
| 05/25/2011 | CN101061109B Novel pyridonecarboxylic acid derivatives or salts thereof |
| 05/25/2011 | CN101056662B Adhesion preventive material and method of preventing adhesion |
| 05/25/2011 | CN101056628B Ester derivatives and medicinal use thereof |
| 05/25/2011 | CN101027286B Indozolone derivatives as 11b-HSD1 inhibitors |
| 05/25/2011 | CN101023056B Levodopa prodrugs, and compositions and uses thereof |
| 05/25/2011 | CN101014576B Aryl spirolactam cgrp receptor antagonists |
| 05/25/2011 | CA2791796A1 Herbal supplement prepared from geranium |
| 05/24/2011 | US7947852 Naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them |
| 05/24/2011 | US7947851 1,1′-(1,2-ethynediyl)bis-benzene derivatives as PTP 1-B inhibitors |
| 05/24/2011 | US7947846 15-OXA-steroid compounds |
| 05/24/2011 | US7947839 Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of use |
| 05/24/2011 | US7947838 Radiolabelled benzamide analogues, their synthesis and use in diagnostic imaging |
| 05/24/2011 | US7947835 Certain substituted amides, method of making, and method of use thereof |
| 05/24/2011 | US7947828 Methods and intermediates for the synthesis of dipyrrin-substituted porphyrinic macrocycles |
| 05/24/2011 | US7947817 Nucleotide blocked with sugar compound; biosynthesis of nucleic acids |
| 05/24/2011 | US7947810 Kits for diagnosing a hypophosphatemic disorder |
| 05/24/2011 | US7947744 Stable pharmaceutical products |
| 05/24/2011 | US7947743 Use of agomelatine in obtaining medicaments intended for the treatment of bipolar disorders |
| 05/24/2011 | US7947742 For treatment of anaphylaxis/respiratory system disorders; spray drying; improved bioavailability |
| 05/24/2011 | US7947741 Use and administration of bacterial efflux pump inhibitors |
| 05/24/2011 | US7947740 Bimatoprost crystalline form I |
| 05/24/2011 | US7947739 Tranexamic acid formulations |
| 05/24/2011 | US7947738 Bicyclic γ-amino acid derivative |
| 05/24/2011 | US7947737 Method of treating hypertension and reducing serum lipase activity |
| 05/24/2011 | US7947736 Oligomeric compounds |
| 05/24/2011 | US7947735 Compounds for the treatment of metabolic disorders |
| 05/24/2011 | US7947733 Phosphorylated pyrone analogs and methods |
| 05/24/2011 | US7947732 Therapeutic substituted chlorocyclopentanols |
| 05/24/2011 | US7947731 Administering an agent that enhances Cyclic AMP response element binding protein (CREB) pathway function, training the animal to improve performance in the cognitive task; for people with central nervous system disorders |
| 05/24/2011 | US7947730 Piperidinium and pyrrolidinium derivatives as ligands for the muscarinic M3 receptor |
| 05/24/2011 | US7947727 Compounds |
| 05/24/2011 | US7947726 Non-steroidal ligands for the glucocorticoid receptor, and compositions thereof |
| 05/24/2011 | US7947725 Liquid pharmaceutical formulations of palonosetron |
| 05/24/2011 | US7947724 Liquid pharmaceutical formulations of palonosetron |
| 05/24/2011 | US7947723 Synthesis and anti-proliferative effect of benzimidazole derivatives |
| 05/24/2011 | US7947722 Imidazolidinone derivative, method of producing the same and method of producing optically active amino acid |
| 05/24/2011 | US7947721 S-triazolyl α-mercaptoacetanilides as inhibitors of HIV reverse transcriptase |
| 05/24/2011 | US7947720 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 05/24/2011 | US7947719 Biologically active compounds obtainable from Sorangium cellulosum |
| 05/24/2011 | US7947718 Isoxazole compounds as histamine H3 modulators |
| 05/24/2011 | US7947717 Inhibitors of lethal factor protease |
| 05/24/2011 | US7947716 N-sulfonylaminocarbonyl containing compounds |
| 05/24/2011 | US7947714 Piperidine glycine transporter inhibitors |
| 05/24/2011 | US7947713 Tripeptidyl peptidase inhibitors |
| 05/24/2011 | US7947712 Antiarthritic agents; asthma; chronic obstructive pulminary diosrders; atherosclerosis; vision defects; hepatitis; central nervous system disorders; cardiovascular disorders; wound healing agents; restenosis; cirrhosis; multiple sclerosis; glomerulonephritis; graft versus host disease; antidiabetic agent |
| 05/24/2011 | US7947711 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 05/24/2011 | US7947710 Disubstituted alkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists |
| 05/24/2011 | US7947709 Non-nucleoside reverse transcriptase inhibitors |
| 05/24/2011 | US7947708 Compounds modulating C-kit activity |
| 05/24/2011 | US7947707 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same |
| 05/24/2011 | US7947706 Substituted pyrrolopyridines, compositions containing them, manufacturing process therefor and use thereof |
| 05/24/2011 | US7947705 7-azaindoles and the use thereof as therapeutic agents |
| 05/24/2011 | US7947703 Phenanthridinium derivatives as DNA binding agents |
| 05/24/2011 | US7947701 Dual molecules containing peroxy derivative, the synthesis and therapeutic applications thereof |
| 05/24/2011 | US7947700 Carboxylic acid amides, the preparation thereof and their use as medicaments |
| 05/24/2011 | US7947699 Anhydrous amorphous imatinib mesylate |
| 05/24/2011 | US7947697 8-(3-pentylamino)-2-methyl-3-(2-chloro-4-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d] pyrazolo[1,5-a]pyrimidine methanesulfonate as a CRF antagonist |
| 05/24/2011 | US7947696 2-amino-4-phenylquinazoline derivatives and the use thereof as HSP90 modulators |
| 05/24/2011 | US7947695 5-membered annelated heterocyclic pyrimidines as kinase inhibitors |
| 05/24/2011 | US7947694 Substituted pyrazolo[3,4-D]pyrimidines as cell cycle kinase inhibitors |
| 05/24/2011 | US7947693 5,7-disubstituted thiazolo[4,5-D]pyrimidines as chemokine inhibitors |
| 05/24/2011 | US7947692 Substituted thiazolo[5,4-d]pyrimidine urea derivatives |
| 05/24/2011 | US7947691 Cyclic n-hydroxy imides as inhibitors of flap endonuclease and uses thereof |
| 05/24/2011 | US7947690 Insulin secretagogue and hypoglycemic agent; pyrimidine derivatives condensed with a non-aromatic ring selected from dihydrothiophene, dihydrofuran, cycloalkane moiety; 1-[2-(4-chloro-2,5-difluorophenyl)-6,6-dioxido-5,7-dihydrothieno[3,4-d]pyrimidin-4-yl]-4-(3-hydroxypropyl)piperidin-4-ol for example |
| 05/24/2011 | US7947689 Substituted pyrazolo[1,5-a]pyrimidines as metabotropic glutamate receptor modulators |
| 05/24/2011 | US7947688 N-[3-(3-substituted-pyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-sulfonamides, and compositions, and methods related thereto |
| 05/24/2011 | US7947687 Antineoplastic and curcumin derivatives and methods of preparation and use |